RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. (IST:RTALB)
Turkey · Delayed Price · Currency is TRY 2.760
+0.010 (0.36%)
At close: Sep 4, 2026
IST:RTALB Revenue
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. had revenue of 83.81M TRY in the quarter ending June 30, 2026, with 27.28% growth. This brings the company's revenue in the last twelve months to 272.72M, up 10.42% year-over-year. In the year 2025, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. had annual revenue of 239.56M with 15.41% growth.
Revenue (ttm)
272.72M
Revenue Growth
+10.42%
P/S Ratio
5.06
Revenue / Employee
3.74M
Employees
73
Market Cap
1.38B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 239.56M | 31.98M | 15.41% |
| Dec 31, 2024 | 207.58M | 69.07M | 49.87% |
| Dec 31, 2023 | 138.51M | -52.79M | -27.59% |
| Dec 31, 2022 | 191.30M | -193.04M | -50.23% |
| Dec 31, 2021 | 384.34M | 153.90M | 66.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.